.jpeg)
2026-05-13 03:19:49
This article dissects the standard duration, long-term risks, and应对 strategies of Pretomanid (core component of BPaL regimen) for drug-resistant TB, highlighting the dangers of exceeding the recommended timeline and offering specialized guidance for patients who have used Pretomanid for three years.
2026-04-27 03:19:03
Cabotegravir Sodium, an advanced integrase strand transfer inhibitor (INSTI), revolutionizes HIV management through its innovative long-acting injectable formulation. Administered every two months, this medication offers a breakthrough in treatment adherence and convenience, particularly for patients requiring flexible regimens.
2026-04-03 06:50:04
Biktarvy (bictegravir/emtricitabine/tenofovir alafenamide) is a next-generation fixed-dose combination (FDC) antiretroviral therapy for HIV. It features minimal food dependence, with consistent absorption and antiviral efficacy whether taken with or without food. The core clinical principle is consistent daily dosing at a fixed time to maintain long-term viral suppression.
2026-04-03 06:26:16
Valganciclovir (Valcyte) is a core antiviral for CMV prevention and treatment in transplant and immunocompromised patients. Its duration is individualized based on immune status, transplant type, virologic monitoring, and risk stratification, balancing efficacy and safety against myelosuppression.
2026-03-24 04:11:29
Cabotegravir Sodium (Vocabria) is an HIV integrase inhibitor for HIV-1 infection treatment and PrEP. This article details headache, liver injury, allergic reactions and monitoring points to help patients use medication safely.
2026-03-20 03:13:56
Cabotegravir sodium is an integrase strand transfer inhibitor used for HIV-1 treatment and pre-exposure prevention, supporting long-acting injection regimens suitable for patients with adherence challenges.
2026-02-03 05:16:24
Isavaconazole capsules are a novel antifungal agent, suitable for the treatment of invasive aspergillosis and mucormycosis in adults and children aged 6 and above with specific body weight.
2025-10-19 11:44:20
